The ROC analysis revealed relatively high differentiating potential of ficolin-1 between the MM patients and controls (curve area−0.72, p < 0.0001, cut-off−1,138 ng/ml, sensitivity−75.4%, specificity−62%). This evidence concerns the gene FCN1 and Miyoshi myopathy.